GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
17.86
+0.12 (0.68%)
At close: Feb 3, 2026
SHA:600771 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 82.37 | 74.45 | 90.08 | -250.02 | -316.24 | 32 |
Depreciation & Amortization | 50.38 | 50.38 | 46.01 | 39.25 | 38.39 | 34.68 |
Other Amortization | 3.77 | 3.77 | 2.55 | 3.12 | 3.14 | 3.35 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.2 | 0.02 | -0.4 | 0.02 |
Asset Writedown & Restructuring Costs | 4.71 | 4.71 | 0.02 | 19.89 | 0.03 | -0.9 |
Loss (Gain) From Sale of Investments | 7.73 | 7.73 | -1.45 | 0.92 | 4.22 | 2.27 |
Provision & Write-off of Bad Debts | 69.36 | 69.36 | 24.76 | 22.2 | -26.03 | 60.55 |
Other Operating Activities | 81 | 23.69 | 23.08 | 51.84 | 8.14 | 28.35 |
Change in Accounts Receivable | 289.01 | 289.01 | 221.08 | 352.25 | 228.78 | -273.12 |
Change in Inventory | -204.87 | -204.87 | -157.6 | -59.63 | 9.76 | 161.14 |
Change in Accounts Payable | -190.49 | -190.49 | -25.66 | 86.1 | 155.62 | -107.42 |
Operating Cash Flow | 177.62 | 112.39 | 215.5 | 253.43 | 81.37 | -75.52 |
Operating Cash Flow Growth | - | -47.85% | -14.96% | 211.45% | - | - |
Capital Expenditures | -8.68 | -8.78 | -2.51 | -8.67 | -18.19 | -49.65 |
Sale of Property, Plant & Equipment | - | 0.04 | 0.23 | 0.03 | 0 | 1.06 |
Investment in Securities | -8.84 | 1.56 | 0.35 | 0.2 | -0.55 | -10.9 |
Other Investing Activities | - | - | 0.74 | 1.02 | 0.86 | 0.82 |
Investing Cash Flow | -17.52 | -7.17 | -1.19 | -7.41 | -17.89 | -58.67 |
Short-Term Debt Issued | - | 11.77 | - | 51.62 | 206.5 | - |
Long-Term Debt Issued | - | - | 56 | 355 | 301.86 | 508 |
Total Debt Issued | 11.77 | 11.77 | 56 | 406.62 | 508.36 | 508 |
Short-Term Debt Repaid | - | - | - | -229.5 | -288.22 | - |
Long-Term Debt Repaid | - | -254.37 | -242.98 | -260.32 | -309.8 | -207.43 |
Total Debt Repaid | -8.77 | -254.37 | -242.98 | -489.82 | -598.02 | -207.43 |
Net Debt Issued (Repaid) | 2.99 | -242.61 | -186.98 | -83.19 | -89.67 | 300.57 |
Common Dividends Paid | -1.19 | -3.95 | -14.33 | -19.8 | -18.31 | -11.04 |
Other Financing Activities | -2.8 | -0.23 | - | - | - | -168.75 |
Financing Cash Flow | -1 | -246.78 | -201.31 | -102.99 | -107.98 | 120.78 |
Net Cash Flow | 159.1 | -141.56 | 13 | 143.03 | -44.5 | -13.42 |
Free Cash Flow | 168.94 | 103.61 | 212.99 | 244.76 | 63.17 | -125.17 |
Free Cash Flow Growth | - | -51.35% | -12.98% | 287.44% | - | - |
Free Cash Flow Margin | 12.17% | 8.48% | 16.59% | 21.65% | 7.40% | -11.28% |
Free Cash Flow Per Share | 0.35 | 0.21 | 0.43 | 0.50 | 0.13 | -0.27 |
Cash Income Tax Paid | 198.35 | 144.12 | 142.15 | 111.09 | 126.71 | 149.03 |
Levered Free Cash Flow | 156.65 | 84.26 | 164.65 | 553.83 | -124.2 | -1.03 |
Unlevered Free Cash Flow | 157.62 | 88.28 | 175.23 | 566.93 | -112.27 | 7.06 |
Change in Working Capital | -121.72 | -121.72 | 30.64 | 366.21 | 370.13 | -235.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.